The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting with key leaders in Alzheimer’s disease research getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.
This year the 14th annual CTAD conference will be on November 9-12, 2021 and will combine an onsite meeting in Boston with on-demand scientific content on a digital platform.
We are pleased that the AMYPAD abstract entitled “Current Status and Quantitative Results of the AMYPAD Prognostic and Natural History Study” has been accepted as an oral communication. Juan Domingo Gispert will be presenting this on Thursday, November 11th at 2:50pm ET or 9:50pm CET (OC20).
Lyduine Collij will be presenting a poster entitled “Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individual” (P19).
Information on conference registrations can be found HERE.